Arkan

Bendtzen

C. M. Reynolds

de Roos

E. Oliver

Elmendorf

F. C. McGillicuddy

Fenkci

Garcia

H. M. Roche

Hirosumi

Hotamisligil

Jung

K. A. Harford

K. H. G. Mills

Kern

Lagathu

Larsen

Llorca

Lumeng

M. Claessens

Maedler

Mills

Niemand

Nishimura

Poggi

Rausch

Shoelson

Somm

Stienstra

Stylianou

Tanaka

Thomas

Ueki

Uysal

van der Poll

Weisberg

Wellen

Winer

Yang

Yuan

English

PubMed


                  OBJECTIVE
                  High-fat diet (HFD)-induced adipose tissue inflammation is a critical feature of diet-induced insulin resistance (IR); however, the contribution of interleukin-1 receptor I (IL-1RI)-mediated signals to this phenotype has not been defined. We hypothesized that lack of IL-1RI may ameliorate HFD-induced IR by attenuating adipose tissue inflammation.
               
               
                  RESEARCH DESIGN AND METHODS
                  Glucose homeostasis was monitored in chow- and HFD-fed wild-type (WT) and IL-1RI−/− mice by glucose tolerance and insulin tolerance tests. Macrophage recruitment and cytokine signature of adipose tissue macrophages was evaluated. Insulin sensitivity and cytokine secretion from adipose explants was quantified. Cytokine secretion and adipocyte insulin sensitivity was measured in cocultures of WT or IL-1RI−/− macrophages with 3T3L1 adipocytes. Synergistic effects of IL-1β with tumor necrosis factor (TNF)-α on inflammation was monitored in WT and IL-1RI−/− bone-marrow macrophages and adipose explants.
               
               
                  RESULTS
                  Lean and obese IL-1RI−/− animals exhibited enhanced glucose homeostasis by glucose tolerance test and insulin tolerance test. M1/M2 macrophage number in adipose tissue was comparable between genotypes; however, TNF-α and IL-6 secretion was lower from IL-1RI−/− adipose tissue macrophages. IL-1RI−/− adipose exhibited enhanced insulin sensitivity, elevated pAKT, lower cytokine secretion, and attenuated induction of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling molecule 3 after HFD. Coculture of WT, but not IL-1RI−/− macrophages, with 3T3L1 adipocytes enhanced IL-6 and TNF-α secretion, reduced adiponectin secretion, and impaired adipocyte insulin sensitivity. TNF-α and IL-1β potently synergized to enhance inflammation in WT macrophages and adipose, an effect lost in the absence of IL-1RI.
               
               
                  CONCLUSIONS
                  Lack of IL-1RI protects against HFD-induced IR coincident with reduced local adipose tissue inflammation, despite equivalent immune cell recruitment.
               </jats:sec

Fiona C. McGillicuddy

Karen A. Harford

Clare M. Reynolds

Elizabeth Oliver

Mandy Claessens

Kingston H.G. Mills

Helen M. Roche

Crossref

Diabetes

Lack of Interleukin-1 Receptor I (IL-1RI) Protects Mice From High-Fat Diet–Induced Adipose Tissue Inflammation Coincident With Improved Glucose Homeostasis

A central role for JNK in obesity and insulin resistance.

Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.

Attenuation of inﬂammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inﬂammation in obesity.

Circulating levels of interleukin-1 family cytokines in overweight adolescents.

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science

Decreased fat mass in interleukin-1 receptor antagonist-deﬁcient mice: impact on adipogenesis, food intake, and energy expenditure.

Down regulation of peroxisome proliferatoractivated receptorgamma expression by inﬂammatory cytokines and its reversal by thiazolidinediones. Diabetologia

Endogenous IL-10 protects mice from death during septic peritonitis.

Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice.

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Guanosine 59-O-(3-thiotriphosphate) (GTPgammaS) stimulation of GLUT4 translocation is tyrosine kinasedependent.

IKK-beta links inﬂammation to obesity-induced insulin resistance.

IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions.

IL-1 receptor deﬁciency slows progression to diabetes in the NOD mouse.

Immune modulation: IL-1, master mediator or initiator of inﬂammation.

Increased inﬂammatory properties of adipose tissue macrophages recruited during diet-induced obesity.

Inﬂammation and insulin resistance.

Inﬂammation and the IKK beta/I kappa B/NFkappa B axis in obesity- and diet-induced insulin resistance.

Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.

Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther

Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Interleukin-1beta-induced insulin resistance in adipocytes through downregulation of insulin receptor substrate-1 expression. Endocrinology

Interleukin-6 stimulates lipolysis in porcine adipocytes.

Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes.

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

mediate insulin resistance in liver-derived cells in response to adipocyte inﬂammation.

Normalization of obesity-associated insulin resistance through immunotherapy.

Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell inﬁltration.

Obesity is associated with macrophage accumulation in adipose tissue.

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

Relationship of serum interleukin-6 and tumor necrosis factor alpha levels with abdominal fat distribution evaluated by ultrasonography in overweight or obese postmenopausal women.

Reversal of obesity- and dietinduced insulin resistance with salicylates or targeted disruption of Ikkbeta.

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.

stress, and diabetes.

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.

The antiinﬂammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia.

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

The inﬂammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity.

The NLRP3 inﬂammasome instigates obesity-induced inﬂammation and insulin resistance.

TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci

TLR4 links innate immunity and fatty acid-induced insulin resistance.

Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3114387

Lack of Interleukin-1 Receptor I (IL-1RI) Protects Mice From High-Fat Diet–Induced Adipose Tissue Inflammation Coincident With Improved Glucose Homeostasis

Abstract

Similar works

Full text

Available Versions

Crossref